| 
				News of their birth prompted global condemnation of the work, 
				raising the ethical specter of so-called designer babies in 
				which embryos could be genetically modified to produce children 
				with desirable traits.
 The scientists and ethicists want to halt genetic alterations of 
				"germline cells" - egg or sperm cells - that can then be 
				inherited by others and "could have permanent and possibly 
				harmful effects on the species."
 
 The global moratorium would be in place until nations can devise 
				international principles to guide how the technology should be 
				used, the experts wrote in the journal Nature. It would not 
				cover gene editing done in embryos for research purposes that 
				would not lead to a live birth.
 
 “The governance framework we are calling for will place major 
				speed bumps in front of the most adventurous plans to 
				re-engineer the human species,” the experts said in a commentary 
				in the Nature. "The introduction of genetic modifications into 
				future generations could have permanent and possibly harmful 
				effects on the species,” they wrote.
 
 Such work differs from research being conducted by numerous drug 
				companies and scientists into gene therapies based on editing 
				so-called somatic cells that affect an individual's health by 
				correcting a disease or condition but would not be passed on to 
				offspring.
 
 Dr. Francis Collins, director of the U.S. National Institutes of 
				Health, said in a letter to the journal that the "NIH strongly 
				agrees" that a ban on the practice should go into immediate 
				effect and stay in place until nations can commit to 
				international rules to determine "whether and under what 
				conditions such research should ever proceed."
 
 “There is no doubt that genome editing technologies hold huge 
				potential," Collins said, but added that there are too many 
				scientific and ethical questions that need to be answered.
 
 Some scientists called the proposed ban unnecessary, saying it 
				would not prevent a scientist bent on using the technology from 
				editing DNA in embryos to prevent disease or enhance traits of a 
				child, as was the case with Chinese researcher He Jiankui.
 
 “We do not think a moratorium would have deterred He Jiankui, 
				who acted secretively and in breach of a clear scientific 
				consensus that germline genome editing should not be used in the 
				clinic at this time,” Sarah Norcross, director of Britain-based 
				Progress Educational Trust, said in a statement.
 
 Helen O'Neill, program director for Reproductive Science and 
				Women's Health at University College London, said the proposal 
				ignores the fact that a global ban already exists.
 
 O'Neill said there were legal and ethical measures in place in 
				China and that He broke many of these rules. "It was not that he 
				did this because the law allowed it."
 
 (Reporting by Julie Steenhuysen; additional reporting by Kate 
				Kelland in London; editing by Bill Berkrot)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
				 
				  |  |